Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
64%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
THNR
18
HOLDINGS
78%
ALSO IN OZEM
OZEM
21
HOLDINGS
67%
ALSO IN THNR
SECTOR DRIFT (THNR minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.2% | 15.8% | 12.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | 8.8% | 11.9% | 8.8% |
|
PFIZER INC | 5.7% | 8.4% | 5.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.1% | 5.1% | 5.1% |
|
AMGEN INC | 6.3% | 4.9% | 4.9% |
THNR Overweight Relative to OZEM
|
REGENERON PHARMACEUTICALS | 6.1% |
|
ABBVIE INC | 5.8% |
|
MERCK & CO. INC. | 5.2% |
|
GILEAD SCIENCES INC | 3.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.6% |
 |
INNOVENT BIOLOGICS, INC. | 2.2% |
 |
ASTRAZENECA PLC | 1.6% |
|
AMGEN INC | 1.4% |
|
CHUGAI PHARMACEUTICAL CO LTD | 0.0% |
|
ZEALAND PHARMA A/S | -0.1% |
THNR Underweight Relative to OZEM
 |
ASCLETIS PHARMA, INC. | -5.4% |
|
KAILERA THERAPEUTICS INC | -4.8% |
|
ELI LILLY & CO | -3.6% |
|
NOVO-NORDISK A/S-SPONS ADR | -3.1% |
|
HANSOH PHARMACEUTICAL GROUP COMPANY | -2.7% |
|
PFIZER INC | -2.6% |
 |
THE UNITED LABORATORIES INTE | -2.5% |
|
MBX BIOSCIENCES INC | -2.0% |
|
RHYTHM PHARMACEUTICALS, INC. | -1.4% |
|
SHIONOGI & CO LTD | -1.4% |